Global left ventricular longitudinal strain is associated with decreased melatonin levels in patients with acute myocardial infarction: a two-dimensional speckle tracking study

References

• Buckberg G, Hoffman JI, Mahajan A, et al. (2008). Cardiac mechanics revisited: the relationship of cardiac architecture to ventricular function. Circulation 118:2571–87
   PubMed Web of Science ®Google Scholar
• Chan J, Hanekom L, Wong C, et al. (2006). Differentiation of subendocardial and transmural infarction using two-dimensional strain rate imaging to assess short-axis and long-axis myocardial function. J Am Coll Cardiol 48:2026–33
   PubMed Web of Science ®Google Scholar
• Dominguez-Rodriguez A. (2012). Melatonin in cardiovascular disease. Expert Opin Investig Drugs 21:1593–6
   PubMed Web of Science ®Google Scholar
• Dominguez-Rodriguez A, Abreu-Gonzalez P, Arroyo-Ucar E, Reiter RJ. (2012a). Decreased level of melatonin in serum predicts left ventricular remodelling after acute myocardial infarction. J Pineal Res 53:319–23
   PubMed Web of Science ®Google Scholar
• Dominguez-Rodriguez A, Abreu-Gonzalez P, Avanzas P. (2012b). The role of melatonin in acute myocardial infarction. Front Biosci 17:2433–41
   Web of Science ®Google Scholar
• Dominguez-Rodriguez A, Abreu-Gonzalez P, Garcia-Gonzalez M, Reiter RJ. (2006). Prognostic value of nocturnal melatonin levels as a novel marker in patients with ST-segment elevation myocardial infarction. Am J Cardiol 97:1162–4
   PubMed Web of Science ®Google Scholar
• Dominguez-Rodriguez A, Abreu-Gonzalez P, Reiter RJ. (2009). Clinical aspects of melatonin in the acute coronary syndrome. Curr Vasc Pharmacol 7:367–73
   PubMed Web of Science ®Google Scholar
• Dominguez-Rodriguez A, Abreu-Gonzalez P, Reiter RJ. (2012c). Melatonin and cardiovascular disease: myth or reality? Rev Esp Cardiol 65:215–18
   PubMed Web of Science ®Google Scholar
• Dominguez-Rodriguez A, Abreu-Gonzalez P, Sanchez-Sanchez JJ, et al. (2010). Melatonin and circadian biology in human cardiovascular disease. J Pineal Res 49:14–22
   PubMed Web of Science ®Google Scholar
• Drobnik J, Slotwinska D, Olczak S, et al. (2011). Pharmacological doses of melatonin reduce the glycosaminoglycan level within the infarcted heart scar. J Physiol Pharmacol 62:29–35
   PubMed Web of Science ®Google Scholar
• Dubocovich ML, Markowska M. (2005). Functional MT1 and MT2 melatonin receptors in mammals. Endocrine 27:101–10
   PubMed Web of Science ®Google Scholar
• Ersbøll M, Valeur N, Mogensen UM, et al. (2012). Global left ventricular longitudinal strain is closely associated with increased neurohormonal activation after acute myocardial infarction in patients with both reduced and preserved ejection fraction: a two-dimensional speckle tracking study. Eur J Heart Fail 14:1121–9
   PubMed Web of Science ®Google Scholar
• Galano A, Tan DX, Reiter RJ. (2011). Melatonin as a natural ally against oxidative stress: a physicochemical examination. J Pineal Res 51:1–16
   PubMed Web of Science ®Google Scholar
• Galano A, Tan DX, Reiter RJ. (2013). On the free radical scavenging activities of melatonin's metabolites, AFMK and AMK. J Pineal Res 54:245--57
   Google Scholar
• Gaudron P, Eilles C, Kugler I, Ertl G. (1993). Progressive left ventricular dysfunction and remodeling after myocardial infarction. Potential mechanisms and early predictors. Circulation 87:755–63
   PubMed Web of Science ®Google Scholar
• Gjesdal O, Hopp E, Vartdal T, et al. (2007). Global longitudinal strain measured by two-dimensional speckle tracking echocardiography is closely related to myocardial infarct size in chronic ischaemic heart disease. Clin Sci (Lond) 113:287–96
   PubMed Web of Science ®Google Scholar
• Korkmaz A, Reiter RJ, Topal T, et al. (2009). Melatonin: an established antioxidant worthy of use in clinical trials. Mol Med 15:43–50
   PubMed Web of Science ®Google Scholar
• Koziróg M, Poliwczak AR, Duchnowicz P, et al. (2011). Melatonin treatment improves blood pressure, lipid profile, and parameters of oxidative stress in patients with metabolic syndrome. J Pineal Res 50:261–6
   PubMed Web of Science ®Google Scholar
• Lang RM, Bierig M, Devereux RB, et al. (2005). Chamber Quantification Writing Group; American Society of Echocardiography's Guidelines and Standards Committee; European Association of Echocardiography. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 18:1440–63
   PubMed Web of Science ®Google Scholar
• Lavie CJ, O'Keefe JH Jr, Chesebro JH, et al. (1990). Prevention of late ventricular dilatation after acute myocardial infarction by successful thrombolytic reperfusion. Am J Cardiol 66:31–6
   PubMed Web of Science ®Google Scholar
• Liu YW, Tsai WC, Su CT, et al. (2009). Evidence of left ventricular systolic dysfunction detected by automated function imaging in patients with heart failure and preserved left ventricular ejection fraction. J Card Fail 15:782–9
   PubMed Web of Science ®Google Scholar
• Nidorf SM, Siu SC, Galambos G, et al. (1993). Benefit of late coronary reperfusion on ventricular morphology and function after myocardial infarction. J Am Coll Cardio 21:683–91
   PubMed Web of Science ®Google Scholar
• Reisner SA, Lysyansky P, Agmon Y, et al. (2004). Global longitudinal strain: a novel index of left ventricular systolic function. J Am Soc Echocardiogr 17:630–3
   PubMed Web of Science ®Google Scholar
• Reiter RJ, Manchester LC, Fuentes-Broto L, Tan DX. (2010). Cardiac hypertrophy and remodelling: pathophysiological consequences and protective effects of melatonin. J Hypertens 28:S7–12
   PubMed Web of Science ®Google Scholar
• Sjøli B, Ørn S, Grenne B, et al. (2009). Comparison of left ventricular ejection fraction and left ventricular global strain as determinants of infarct size in patients with acute myocardial infarction. J Am Soc Echocardiogr 22:1232–8
   PubMed Web of Science ®Google Scholar
• Solomon SD, Glynn RJ, Greaves S, et al. (2001). Recovery of ventricular function after myocardial infarction in the reperfusion era: the healing and early afterload reducing therapy study. Ann Intern Med 134:451–8
   PubMed Web of Science ®Google Scholar
• Stanton T, Leano R, Marwick TH. (2009). Prediction of all-cause mortality from global longitudinal speckle strain: comparison with ejection fraction and wall motion scoring. Circ Cardiovasc Imag 2:356–64
   PubMed Web of Science ®Google Scholar
• Stehle JH, Saade A, Rawashdeh O, et al. (2011). A survey of molecular details in the human pineal gland in the light of phylogeny, structure, function and chronobiological diseases. J Pineal Res 51:17–43
   PubMed Web of Science ®Google Scholar
• Tan DX, Manchester LC, Terron MP, et al. (2007). One molecule, many derivatives: a never-ending interaction of melatonin with reactive oxygen and nitrogen species? J Pineal Res 42:28–42
   PubMed Web of Science ®Google Scholar
• Tengattini S, Reiter RJ, Tan DX, et al. (2008). Cardiovascular diseases: protective effects of melatonin. J Pineal Res 44:16–25
   PubMed Web of Science ®Google Scholar
• Van de Werf F, Bax J, Betriu A, et al. (2009). ESC guidelines on management of acute myocardial infarction in patients presenting with persistent ST-segment elevation. Rev Esp Cardiol 62:e1–47
   Web of Science ®Google Scholar
• Vinereanu D, Lim PO, Frenneaux MP, Fraser AG. (2005). Reduced myocardial velocities of left ventricular long-axis contraction identify both systolic and diastolic heart failure – a comparison with brain natriuretic peptide. Eur J Heart Fail 7:512–19
   PubMed Web of Science ®Google Scholar